Skip to main content
Clinical Trials/NL-OMON45389
NL-OMON45389
Completed
Not Applicable

Effects of neuromuscular blockade on transpulmonary pressure and diaphragm activity in paediatric moderate-to-severe acute respiratory distress syndrome: a pilot study - PedNMB.2

niversitair Medisch Centrum Groningen0 sites19 target enrollmentTBD
ConditionsPARDS10038716

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
PARDS
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
19
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Informed consent
  • Age younger than 12 years
  • Need for mechanical ventilation with tidal volume 5 \- 8 mL/kg ideal bodyweight and a mimum PEEP level of 5 cmH2O
  • Early moderate \- to \- severe paediatric acute respiratory distress syndrome originating from any cause:
  • Acute onset of disease, and
  • Oxygenation index \> 12, and
  • One or more (bilateral) infiltrates on chest radiograph, and
  • No evidence of left ventricular failure or fluid overload, and
  • Within the first 48 hours of diagnosis of PARDS
  • Indication for continuous infusion of NMBAs at discretion of the attending physician

Exclusion Criteria

  • No informed consent
  • Continuous administration of neuromuscular blockade prior at the time of meeting the criteria for PARDS
  • Chronic respiratory failure on home ventilation
  • Intracranial hypertension
  • Bone marrow transplantation
  • Immunocompromised patients (congenital or acquired)
  • Pre\-existing pulmonary hypertension
  • Congenital heart disease with left \- to \- right shunting
  • Cyanotic congenital heart disease
  • Withdrawal of life \- sustaining treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials